Skip to main content
. 2022 Aug 3;9(6):3814–3824. doi: 10.1002/ehf2.14077

Figure 2.

Figure 2

(A) Combined endpoint of death or cardiovascular readmission of study participants with or without improvement in TAPSE with acute treatment (unadjusted). (B) Combined endpoint of death or cardiovascular readmission of study participants with or without improvement in TAPSE with acute treatment (adjusted).